CATX Other Income/Expenses (Net)
Perspective Therapeutics Inc · Other Income/Expenses (Net)
CATX Other Income/Expenses (Net)
Latest reported$8.00Mperiod ending
CATX TTM Other Income/Expenses (Net) (-$53.62K → $8.00M)
TTM Other Income/Expenses (Net)
High-resolution chart · PNG
CATX other income/expenses (net) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| 8,004,000 | |
| 7,573,000 | |
| 8,993,000 | |
| 10,162,000 | |
| 11,782,000 | |
| 10,924,000 | |
| 7,590,000 | |
| 3,808,000 | |
| 579,000 | |
| -335,000 | |
| -179,000 | |
| 1,187,000 | |
| 1,044,000 | |
| 804,000 | |
| 499,000 | |
| 228,000 | |
| 119,000 | |
| 123,000 | |
| 115,000 | |
| 89,000 | |
| 59,000 | |
| 28,000 | |
| 10,000 | |
| -34,000 | |
| -32,000 | |
| 205,000 | |
| 205,000 | |
| 267,000 | |
| 300,000 | |
| 77,000 | |
| -1,000 | |
| -106,000 | |
| -135,000 | |
| -170,000 | |
| -117,000 | |
| -26,000 | |
| 14,000 | |
| 52,000 | |
| 152,000 | |
| 186,000 | |
| 154,000 | |
| 135,000 | |
| 85,605 | |
| 83,605 | |
| 374,605 | |
| 26,350 | |
| -1,136,116 | |
| -1,045,034 | |
| -1,387,034 | |
| -1,010,779 | |
| 232,082 | |
| 45,000 | |
| 210,000 | |
| -26,095 | |
| 78,000 | |
| 299,000 | |
| 383,095 | |
| 669,190 | |
| 293,095 | |
| 696,974 | |
| 320,879 | |
| 813,758 | |
| 976,758 | |
| 406,879 | |
| 569,879 | |
| 0 | |
| 0 | |
| 433,200 | |
| 274,000 | |
| 187,300 | |
| 0 | |
| -519,900 | |
| -548,000 | |
| -461,300 | |
| -274,000 | |
| -187,300 | |
| 0 | |
| 432,257 | |
| 209,694 | |
| -34,403 | |
| -256,966 | |
| 1,423,838 | |
| 1,486,401 | |
| 1,730,498 | |
| 1,953,061 | |
| -163,000 | |
| -6,000 | |
| -9,000 | |
| -12,000 | |
| -12,025 | |
| -21,047 | |
| -31,026 | |
| -41,005 | |
| -50,855 | |
| -51,708 | |
| -51,604 | |
| -51,500 | |
| -50,783 | |
| -50,783 | |
| -50,783 |